Search results
Surmodics Inc (SRDX) Reports Fiscal Year 2023 Earnings Growth and Introduces FY 2024 Guidance
GuruFocus.com via Yahoo Finance· 6 months agoSurmodics Inc (NASDAQ:SRDX) reports an 8% increase in Q4 FY 2023 total revenue, reaching $28.0...
It Looks Like Surmodics, Inc.'s (NASDAQ:SRDX) CEO May Expect Their Salary To Be Put Under The...
Simply Wall St. via Yahoo Finance· 1 year agoSurmodics, Inc. (NASDAQ:SRDX) has not performed well recently and CEO Gary Maharaj will probably...
Surmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: Increased by 23% year-over-year to $30.6 million. Medical Device Segment: Revenue up...
Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSurmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript April 26, 2023 Surmodics, Inc. beats...
Here's Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Surmodics will host its Annual General Meeting on 8th of February Salary of US$640.4k...
Surmodics (SRDX) Stock Skids 32% on Negative Regulatory Update
Zacks via Yahoo Finance· 1 year agoShares of Surmodics, Inc. SRDX have declined 31.8% since the close on Jan 18, following...
Surmodics (SRDX) Q4 Earnings and Revenues Top Estimates
Zacks via Yahoo Finance· 2 years agoSurmodics, Inc. SRDX delivered an adjusted loss per share of 26 cents in the fiscal fourth quarter...
Surmodics, Inc. (NASDAQ:SRDX) Stocks Shoot Up 36% But Its P/S Still Looks Reasonable
Simply Wall St. via Yahoo Finance· 1 year agoSurmodics, Inc. (NASDAQ:SRDX) shareholders are no doubt pleased to see that the share price has...
In the wake of Surmodics, Inc.'s (NASDAQ:SRDX) latest US$31m market cap drop, institutional owners...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies Surmodics' stock price is sensitive...
Are Surmodics, Inc.'s (NASDAQ:SRDX) Mixed Financials Driving The Negative Sentiment?
Simply Wall St. via Yahoo Finance· 2 months agoSurmodics (NASDAQ:SRDX) has had a rough month with its share price down 8.9%. It is possible that...